These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 33487159)

  • 1. [Circulating Neuregulin-1 and Chronic Heart Failure with Preserved Ejection].
    Shchendrigina AA; Zhbanov KA; Privalova EV; Iusupova AO; Bytdaeva AH; Danilogorskaya YA; Zheleznykh EA; Suvorov AY; Zektser VY; Mnatsakanyan MG; Lyapidevskaya OV; Khabarova NV; Naymann YI; Belenkov YN; Starostina ES
    Kardiologiia; 2020 Dec; 60(11):1222. PubMed ID: 33487159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory actions of the NRG-1/ErbB4 pathway in macrophages during tissue fibrosis in the heart, skin, and lung.
    Vermeulen Z; Hervent AS; Dugaucquier L; Vandekerckhove L; Rombouts M; Beyens M; Schrijvers DM; De Meyer GRY; Maudsley S; De Keulenaer GW; Segers VFM
    Am J Physiol Heart Circ Physiol; 2017 Nov; 313(5):H934-H945. PubMed ID: 28822966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
    Paulus WJ; Tschöpe C
    J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
    Poulsen SH
    Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic Neuregulin-1β Treatment Mitigates the Progression of Postmyocardial Infarction Heart Failure in the Setting of Type 1 Diabetes Mellitus by Suppressing Myocardial Apoptosis, Fibrosis, and Key Oxidant-Producing Enzymes.
    Gupte M; Lal H; Ahmad F; Sawyer DB; Hill MF
    J Card Fail; 2017 Dec; 23(12):887-899. PubMed ID: 28870731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central neuregulin-1/ErbB signaling modulates cardiac function via sympathetic activity in pressure overload-induced heart failure.
    Matsukawa R; Hirooka Y; Ito K; Honda N; Sunagawa K
    J Hypertens; 2014 Apr; 32(4):817-25. PubMed ID: 24406781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of endogenous serum neuregulin-1β on morbidity and mortality in patients with heart failure and left ventricular systolic dysfunction.
    Miao J; Huang S; Su YR; Lenneman CA; Wright M; Harrell FE; Sawyer DB; Lenihan DJ
    Biomarkers; 2018 Nov; 23(7):704-708. PubMed ID: 29871526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuregulin as a heart failure therapy and mediator of reverse remodeling.
    Galindo CL; Ryzhov S; Sawyer DB
    Curr Heart Fail Rep; 2014 Mar; 11(1):40-9. PubMed ID: 24234399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuregulin-1/ErbB signaling and chronic heart failure.
    Xu Y; Li X; Liu X; Zhou M
    Adv Pharmacol; 2010; 59():31-51. PubMed ID: 20933198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of endothelial autocrine NRG1/ERBB4 signaling in cardiac remodeling.
    Dugaucquier L; Feyen E; Mateiu L; Bruyns TAM; De Keulenaer GW; Segers VFM
    Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H443-H455. PubMed ID: 32618511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation.
    Ter Maaten JM; Damman K; Verhaar MC; Paulus WJ; Duncker DJ; Cheng C; van Heerebeek L; Hillege HL; Lam CS; Navis G; Voors AA
    Eur J Heart Fail; 2016 Jun; 18(6):588-98. PubMed ID: 26861140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Phase II, randomized, double-blind, multicenter, based on standard therapy, placebo-controlled study of the efficacy and safety of recombinant human neuregulin-1 in patients with chronic heart failure.
    Gao R; Zhang J; Cheng L; Wu X; Dong W; Yang X; Li T; Liu X; Xu Y; Li X; Zhou M
    J Am Coll Cardiol; 2010 May; 55(18):1907-14. PubMed ID: 20430261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parenteral administration of recombinant human neuregulin-1 to patients with stable chronic heart failure produces favourable acute and chronic haemodynamic responses.
    Jabbour A; Hayward CS; Keogh AM; Kotlyar E; McCrohon JA; England JF; Amor R; Liu X; Li XY; Zhou MD; Graham RM; Macdonald PS
    Eur J Heart Fail; 2011 Jan; 13(1):83-92. PubMed ID: 20810473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of neuregulin-1/ErbB signaling in cardiovascular physiology and disease: implications for therapy of heart failure.
    Lemmens K; Doggen K; De Keulenaer GW
    Circulation; 2007 Aug; 116(8):954-60. PubMed ID: 17709650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of the Multitasking Endothelial Protein NRG-1 as a Compensatory Factor During Chronic Heart Failure.
    De Keulenaer GW; Feyen E; Dugaucquier L; Shakeri H; Shchendrygina A; Belenkov YN; Brink M; Vermeulen Z; Segers VFM
    Circ Heart Fail; 2019 Oct; 12(10):e006288. PubMed ID: 31607147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The protective role of neuregulin-1: A potential therapy for sepsis-induced cardiomyopathy.
    Zhou Q; Pan X; Wang L; Wang X; Xiong D
    Eur J Pharmacol; 2016 Oct; 788():234-240. PubMed ID: 27346832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes-Induced Cardiomyocyte Passive Stiffening Is Caused by Impaired Insulin-Dependent Titin Modification and Can Be Modulated by Neuregulin-1.
    Hopf AE; Andresen C; Kötter S; Isić M; Ulrich K; Sahin S; Bongardt S; Röll W; Drove F; Scheerer N; Vandekerckhove L; De Keulenaer GW; Hamdani N; Linke WA; Krüger M
    Circ Res; 2018 Jul; 123(3):342-355. PubMed ID: 29760016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mouse model of heart failure with preserved ejection fraction due to chronic infusion of a low subpressor dose of angiotensin II.
    Regan JA; Mauro AG; Carbone S; Marchetti C; Gill R; Mezzaroma E; Valle Raleigh J; Salloum FN; Van Tassell BW; Abbate A; Toldo S
    Am J Physiol Heart Circ Physiol; 2015 Sep; 309(5):H771-8. PubMed ID: 26188021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuregulin-1 and its potential role in the control of cardiac function.
    Lemmens K; Doggen K; Keulenaer GW
    Heart Fail Monit; 2008 Feb; 5(4):119-24. PubMed ID: 18273495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship Between Focal and Diffuse Fibrosis Assessed by CMR and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction.
    Kanagala P; Cheng ASH; Singh A; Khan JN; Gulsin GS; Patel P; Gupta P; Arnold JR; Squire IB; Ng LL; McCann GP
    JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 2):2291-2301. PubMed ID: 30772227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.